ARCH Venture Partners X, LLC - 10%+ Owner at Verve Therapeutics, Inc.

Issuer-level insider activity

Role: 10%+ Owner
Issuer ticker: VERV
Entity type: Company
Source filing history: Open source filing history

No buys or sells have been reported by ARCH Venture Partners X, LLC since 26 Aug 2025

Reported holdings for ARCH Venture Partners X, LLC in Verve Therapeutics, Inc.

Form 4 holding 10%+ Owner

Verve Therapeutics, Inc.

Security class: Common Stock, par value $0.001
Shares / value: 1,254,405
Estimated value: $12,544,050
Report date: 21 Jun 2021
Price: $10.00
Ownership: ARCH Venture Fund X Overage, L.P.

Form 4 holding 10%+ Owner

Verve Therapeutics, Inc.

Security class: Common Stock, par value $0.001
Shares / value: 1,254,404
Estimated value: $12,544,040
Report date: 21 Jun 2021
Price: $10.00
Ownership: ARCH Venture Fund X, L.P.

Form 4 holding 10%+ Owner

Verve Therapeutics, Inc.

Security class: Series A-2 Convertible Preferred Stock
Shares / value: 0
Estimated value
Report date: 21 Jun 2021
Price
Ownership: Indirect
Underlying class: Common Stock
Underlying amount

Form 4 holding 10%+ Owner

Verve Therapeutics, Inc.

Security class: Series A Convertible Preferred Stock
Shares / value: 0
Estimated value
Report date: 21 Jun 2021
Price
Ownership: Indirect
Underlying class: Common Stock
Underlying amount

Transaction history for ARCH Venture Partners X, LLC in Verve Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .